You complete an online health questionnaire that covers medical history, current medications, weight loss goals, and any contraindications
10.3389/fimmu.2023.1148209 120 MinzeM
Liraglutide has more years of post-market safety data (since 2010), but tirzepatide clinical trials involved large patient populations with rigorous safety monitoring
The SURPASS-CVOT study represents the most comprehensive incretin analysis to date, comparing MACE rates in 13k T2D patients with ASCVD on either Mounjaro or Trulicity over a four year follow-up, finding that MACE risk was 8% lower with Mounjaro
They may not have Dihexa-specific guidance but can speak to your overall medication situation
The FDA (and reputable compounding facilities) realized the importance of identifying which compounding pharmacies can perform large-scale production in a responsible manner, leading to the signing of the Drug Quality and Security Act (DSCSA) in 2013